The randomized NLST had shown that three rounds of annual screening with low-dose CT reduced lung cancer mortality by 20% among current and former smokers as compared with the same number of annual ...
Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depend on the ability to deliver tiny particles known as aerosols to the correct location in ...
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their ...
A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in ...
BI 3720931 is a first-in-class, inhaled lentiviral vector-based gene therapy that could potentially address unmet needs by inserting a functional copy of the CFTR gene in the DNA of airway epithelial ...
Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...
This pathology is largely undiagnosed within existing TB management pathways, but is meaningful for patient outcomes, with accelerated lung function decline, ongoing respiratory-related health seeking ...
Sionna Therapeutics is eyeing a $156 million IPO as the cystic-fibrosis-focused biotech looks to take its lead candidate into phase 2. The Waltham, Massachusetts-based company already unveiled ...
Lung cancer screening aims to find lung cancer early. This is when there are more treatment options available and there is the best chance of treating it successfully. In the UK, the National ...
The gold standard for finding lung cancer early is computed tomography (CT) lung cancer screening. However, this is limited to people who have smoked. Currently, there are more non-smokers (never ...
Usually, you’ll also have a fever and chills with an abscess. Cysts are pockets of fluid, but they aren’t usually infected. If they are large, they may make you uncomfortable, mostly because ...